Recombinant Human TWEAK (TNFSF12) was expressed in E. coli cells.
Catalog No. T893-40N
| Catalog No. | Pack Size | Price (USD) | |
|---|---|---|---|
| T893-40N-25 | 25 ug | $204 | |
| T893-40N-500 | 500 ug | $2756 | |
| T893-40N-BULK | BULK | Contact Us |
Overview:
TWEAK is a TNF superfamily transmembrane protein which is expressed in many different cells and tissues, such as the heart, spleen and small intestine. Two different receptors have been identified that bind TWEAK; the Death Receptor 3 (DR3) and the TWEAK Receptor (TWEAKR). While DR3 is expressed mainly in tissues that have high concentration of lymphocytes, the mitogen-inducible TWEAKR is has been shown to be expressed in fibroblasts, hepetocellular carcinomas and endothelial cells. Recombinant human TWEAK comprises the TNF homologous (secreted region) of TWEAK.
Genbank Number:
Storage, Stability and Shipping:
The lyophilized protein is stable for at least one year from date of receipt at -70oC. Upon reconstitution, this cytokine can be stored in working aliquots at 2o - 8oC for one month, or at -20oC for six months, with a carrier protein without detectable loss of activity. Avoid repeated freeze/thaw cycles.
Endotoxin Level:
<1.0 EU/μg of recombinant protein as determined by the LAL method.
Molecular Weight:
17.2 kDa
Gene Aliases :
TWEAK, Tumor necrosis factor ligand superfamily member 12, TNFSF12, DR3LG, Apo3-Ligand, Recombinant Human TNF-Related Weak Inducer of Apoptosis (TNFSF12)
Reconstitution Protocol:
Reconstitute at 0.1mg/ml/mL in sterile PBS containing at least 0.1% human or bovine serum albumin
Purity:
Recombinant Human TWEAK (TNFSF12) resolved on a 15% SDS-PAGE gel under reducing conditions and stained with Coomassie Brilliant Blue G-250
|
There are no related publications available for this product.
Cancer
STAY CONNECTED
Fax: 1-604-232-4601
Toll Free: 1-866-954-6273
info@signalchem.com